COX-2 AGAIN: Sorry, we haven’t finished with you yet
For years, non-specific anti-inflammatory drugs such as aspirin and paracetamol (acetaminophen) were the medications of choice for joint pain. But NSAIDs quickly became COX-2 inhibitors associated with adverse gastrointestinal effects such as peptic...
In the heady world of the pharmaceutical industry, the most profitable industry in the world - where world sales doubled in the last five years - the pressure is always intense to develop new product.
Vioxx (rofecoxib) is the first of a new kind of analgesic to be licensed in the UK. It employs a pioneering technology called COX-2 (selective cyclo oygenase 2 inhibitors), which is supposed to o ...
Rofecoxib is one of the new breed of anti-inflammatories known as COX-2 (cyclo-oxygenase-2) inhibitors that are supposed to be safer than NSAIDs such as aspirin.
The drugs industry has, for years, enjoyed a protected and privileged position that has allowed it to kill sections of its market with impunity. Sadly, those heady days seem to be coming to an end, at least in the United States.
ALZHEIMER'S: Now let's try an arthritis drug for it (Or; The Resourcef